BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31425694)

  • 1. Amyloidosis of the bladder and association with urothelial carcinoma: report of 29 cases.
    Sirohi D; Gandhi J; Amin MB; Luthringer DJ
    Hum Pathol; 2019 Nov; 93():48-53. PubMed ID: 31425694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive micropapillary urothelial carcinoma: a clinicopathologic study of 18 cases.
    Amin A; Epstein JI
    Hum Pathol; 2012 Dec; 43(12):2124-8. PubMed ID: 22939957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of denuded urothelium in papillary urothelial lesions.
    Owens CL; Epstein JI
    Am J Surg Pathol; 2007 Feb; 31(2):298-303. PubMed ID: 17255776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary amyloidosis with high grade transitional cell carcinoma of bladder: a rare case report.
    Gupta P; Hanamshetti S; Kulkarni JN
    J Cancer Res Ther; 2012; 8(2):297-9. PubMed ID: 22842380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extravesical Pagetoid Spread of Urothelial Carcinoma in Situ. A Report of Five Cases.
    Akgul M; Bomeisl PB; MacLennan GT
    Anal Quant Cytopathol Histpathol; 2015 Dec; 37(6):364-8. PubMed ID: 26860012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive papillary urothelial neoplasia (NIPUN): Renaming cancer.
    Jones TD; Cheng L
    Urol Oncol; 2021 May; 39(5):286-290. PubMed ID: 35550107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urothelial dysplasia of the bladder: diagnostic features and clinical significance.
    Lopez-Beltran A; Montironi R; Vidal A; Scarpelli M; Cheng L
    Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):121-9. PubMed ID: 24344498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced immunohistochemical PTEN staining is associated with higher progression rate and recurrence episodes in non-invasive low-grade papillary urothelial carcinoma of the bladder.
    Kulac I; Arslankoz S; Netto GJ; Ertoy Baydar D
    Virchows Arch; 2018 Jun; 472(6):969-974. PubMed ID: 29368083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Villous adenoma of the urinary tract: a lesion frequently associated with malignancy.
    Seibel JL; Prasad S; Weiss RE; Bancila E; Epstein JI
    Hum Pathol; 2002 Feb; 33(2):236-41. PubMed ID: 11957151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SLC14A1 (UT-B) gene rearrangement in urothelial carcinoma of the bladder: a case report.
    Guo Z; Niu X; Fu G; Yang B; Chen G; Sun S
    Diagn Pathol; 2020 Jul; 15(1):94. PubMed ID: 32703295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of atypical papillary urothelial hyperplasia.
    Swierczynski SL; Epstein JI
    Hum Pathol; 2002 May; 33(5):512-7. PubMed ID: 12094376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of ProEx C in the histologic evaluation of the neoplastic and nonneoplastic urothelial lesions.
    Moatamed NA; Vergara-Lluri ME; Lu D; Apple SK; Kerkoutian S; Rao JY
    Hum Pathol; 2013 Nov; 44(11):2509-17. PubMed ID: 24029711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of minor high grade component in non-invasive papillary urothelial carcinoma of urinary bladder: (A study of 273 consecutive cases over a period of 3 years).
    Syed M; Mushtaq S; Loya A; Hassan U; Mir K; Hussain M; Hameed M; Sheikh UN
    Ann Diagn Pathol; 2023 Apr; 63():152079. PubMed ID: 36549142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urothelial Carcinoma In Situ (CIS): New Insights.
    Akhtar M; Al-Bozom IA; Ben Gashir M; Taha NM; Rashid S; Al-Nabet ADMH
    Adv Anat Pathol; 2019 Sep; 26(5):313-319. PubMed ID: 31149909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexistence of papillary and nodular carcinomas in the urinary bladder.
    Kakizoe T; Matsumoto K; Tobisu K; Takai K; Teshima S; Kishi K
    Jpn J Clin Oncol; 1987 Jun; 17(2):179-86. PubMed ID: 3613141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology.
    Alsheikh A; Mohamedali Z; Jones E; Masterson J; Gilks CB
    Mod Pathol; 2001 Apr; 14(4):267-72. PubMed ID: 11301341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
    Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
    Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases.
    Guo CC; Fine SW; Epstein JI
    Am J Surg Pathol; 2006 Jul; 30(7):883-91. PubMed ID: 16819332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis.
    Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE
    Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.